P813: MALIGNANT PLASMA CELLS PROMOTE EXPANSION OF REGULATORY T CELLS TO CREATE A PROTECTIVE “IMMUNE SHIELD”

• Roberto Limongello,
• Antonella Mancusi,
• Andrea Marra,
• Yu Jia Shen,
• Eni Hoxha,
• Gianvito Pasciolla,
• Flavia Lotti,
• Elisabetta Agliani,
• Andrea Velardi,
• Maria Paola Martelli,
• Alessandra Carotti,
• Stelvio Ballanti,
• Irene Ghobrial,
• Loredana Ruggeri,
• Cristina Mecucci,
• Antonio Pierini

Affiliations

Roberto Limongello

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Antonella Mancusi

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Andrea Marra

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Yu Jia Shen

2 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA, USA., United States

Eni Hoxha

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Gianvito Pasciolla

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Flavia Lotti

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Elisabetta Agliani

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Andrea Velardi

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Maria Paola Martelli

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Alessandra Carotti

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Stelvio Ballanti

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Irene Ghobrial

2 Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA, USA., United States

Loredana Ruggeri

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Cristina Mecucci

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy

Antonio Pierini

1 CREO - Centro di Ricerca Emato-Oncologica, Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy., ANT’ ANDREA DELLE FRATTE Perugia (PG), Italy, Italy